Acute Bleeding Management

The American Academy of Otolaryngology-Head and Neck Surgery recommends applying oxymetazoline (Afrin) or phenylephrine nasal spray directly to the bleeding site, followed by firm nasal compression for 5 minutes, to control acute bleeding episodes in patients on oxygen therapy 1, 2, 3
Over-the-counter vasoconstrictors achieve bleeding control in 65-75% of patients, according to the American Academy of Otolaryngology-Head and Neck Surgery guidelines 1, 4, 5

Prevention Strategy

The American Academy of Otolaryngology-Head and Neck Surgery suggests using nasal saline spray or gel multiple times daily to maintain nasal moisture and prevent epistaxis in patients on oxygen therapy 1, 2, 3
Continue moisturization even after bleeding resolves to prevent recurrence, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 3

Oxymetazoline 0.05% (Afrin) - 2 sprays per nostril, is recommended by the American Academy of Otolaryngology-Head and Neck Surgery for acute bleeding control 1, 4, 6
Phenylephrine nasal spray is an alternative recommended by the American Academy of Otolaryngology-Head and Neck Surgery for acute bleeding control 1, 2, 4

The American Academy of Otolaryngology-Head and Neck Surgery warns against using oxymetazoline or phenylephrine continuously for more than 3-5 days due to the risk of rhinitis medicamentosa (rebound congestion) 1, 2, 6
Vasoconstrictors can cause systemic complications in patients with hypertension, cardiovascular disease, or glaucoma, according to the American Academy of Otolaryngology-Head and Neck Surgery guidelines 1, 2

The American Academy of Otolaryngology-Head and Neck Surgery recommends a practical algorithm for managing oxygen-related nosebleeds, including daily prevention with nasal saline gel or spray, applying oxymetazoline spray and compressing the nose for 5-15 minutes if bleeding starts, and resuming saline moisturization immediately after bleeding stops 1, 3

Apply 2–3 sprays of 0.05 % oxymetazoline per nostril directly to the visible bleeding site, keeping the bottle upright, then perform firm nasal compression of the lower third of the nose for 5–15 minutes. This regimen is recommended for immediate control of acute nosebleeds. 7

Limit oxymetazoline use to a maximum of 3–5 consecutive days; extending therapy beyond this period precipitates rhinitis medicamentosa (rebound nasal congestion) that worsens the clinical picture. The American Academy of Otolaryngology‑Head and Neck Surgery stresses this as a hard stop. 8

In patients receiving anticoagulant or antiplatelet therapy, oxymetazoline may be insufficient; if bleeding persists despite compression, resorbable nasal packing should be considered as the next step. [9][7]

If bleeding continues after the recommended spray and compression, proceed to nasal packing, preferentially using resorbable material for anticoagulated individuals. [9][7]
After clot removal, perform an anterior rhinoscopic examination to locate the bleeding source. 10
Persistent bleeding that tracks into the posterior pharynx during compression suggests a posterior source and warrants more aggressive intervention. 7